Skip to main content
. 2015 Nov 3;10(11):e0141607. doi: 10.1371/journal.pone.0141607

Table 2. Participant Characteristics.

CHF group Control group
n % n % χ 2
Proportion of men (%) 20 65.0 27 71.0 0.34
Cardiac risk factors (%)
 Hypercholesterolemia 13 41.9% 15 39.5% 0.04
 Hypertension 21 67.7% 18 47.4% 2.88
 Smoking 13 41.9% 8 21.1% 3.52
 Diabetes 7 22.6% 4 10.5% 1.85
 Obesity 5 16.1% 2 5.3% 2.21
Demographic (M) M SD M SD t d
 Age (years) 31 69.77 11.23 38 67.13 7.53 1.12 0.28
 Education (years) 31 11.65 3.74 38 13.07 3.57 1.61 0.39
 Estimated IQ 30 112.54 5.89 38 114.33 6.38 1.19 0.29
Global cognition and mental health
 Global cognition (ACE-R) 31 91.00 4.89 38 92.08 4.55 0.95 0.23
 Anxiety (HADS) 31 6.03 3.73 38 8.29 4.51 2.23* 0.55
 Depression (HADS) 31 5.19 2.91 38 5.55 3.29 0.48 0.12
Executive functions
 Cognitive flexibility (TMT) 27 74.83 35.17 37 49.19 31.35 3.07** 0.77
 Inhibition (Hayling) 28 2.89 2.01 35 5.57 1.61 5.88*** 1.47
 Initiation (Verbal fluency) 31 29.94 6.51 38 32.21 7.85 1.29 0.31
Verbal memory (RAVLT)
 Immediate recall 26 41.58 8.89 38 45.00 8.96 1.51 0.38
 Delayed recall 24 8.83 2.51 38 9.13 2.84 0.42 0.11

d = Cohen’s d index of effect size. Effect sizes: small = 0.2; medium = 0.5; large = 0.8 [48].

* p < .05.

** p < .01.

*** p < .001.

Notes. ACE-R = Addenbrooke’s Cognitive Examination—Revised; HADS = Hospital Anxiety Depression Scale; RAVLT = Rey Auditory Verbal Learning Test; TMT = Trail Making Test (B minus A).